PLUS THERAPEUTICS, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Plus Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q3 2024.
  • Plus Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $32K, unchanged year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $32K $0 0% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $32K +$20K +167% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $32K +$20K +167% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $32K +$20K +167% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $32K +$20K +167% Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $12K -$4K -25% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $12K -$4K -25% Mar 31, 2023 10-Q 2023-04-20
Q4 2022 $12K -$4K -25% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $12K -$4K -25% Sep 30, 2022 10-Q 2022-10-20
Q2 2022 $16K $0 0% Jun 30, 2022 10-Q 2022-07-21
Q1 2022 $16K $0 0% Mar 31, 2022 10-Q 2022-04-21
Q4 2021 $16K $0 0% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $16K -$2K -11.1% Sep 30, 2021 10-Q 2021-10-21
Q2 2021 $16K -$2K -11.1% Jun 30, 2021 10-Q 2021-07-22
Q1 2021 $16K -$42K -72.4% Mar 31, 2021 10-Q 2021-04-22
Q4 2020 $16K -$56K -77.8% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $18K -$34K -65.4% Sep 30, 2020 10-Q 2020-10-22
Q2 2020 $18K -$32K -64% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $58K +$18K +45% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $72K +$33K +84.6% Dec 31, 2019 10-K 2021-02-22
Q3 2019 $52K -$1.89M -97.3% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $50K -$2M -97.6% Jun 30, 2019 10-Q 2019-08-15
Q1 2019 $40K -$2.14M -98.2% Mar 31, 2019 8-K 2019-09-10
Q4 2018 $39K -$3K -7.14% Dec 31, 2018 10-K 2020-03-30
Q3 2018 $1.94M +$84K +4.53% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $2.05M +$336K +19.6% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $2.18M +$174K +8.67% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 $42K -$2.29M -98.2% Dec 31, 2017 8-K 2019-09-10
Q3 2017 $1.85M +$380K +25.8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $1.71M +$263K +18.2% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 $2.01M +$326K +19.4% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 $2.34M +$815K +53.6% Dec 31, 2016 10-K 2018-03-09
Q3 2016 $1.47M +$260K +21.4% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $1.45M -$31K -2.1% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $1.68M -$103K -5.77% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $1.52M -$242K -13.7% Dec 31, 2015 10-K 2017-03-24
Q3 2015 $1.21M -$1.08M -47% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $1.48M -$1.09M -42.3% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $1.79M -$627K -26% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $1.76M -$1.05M -37.3% Dec 31, 2014 10-K 2016-03-11
Q3 2014 $2.29M +$329K +16.8% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $2.57M +$119K +4.86% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $2.41M -$396K -14.1% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $2.81M +$72K +2.63% Dec 31, 2013 10-K 2015-03-16
Q3 2013 $1.96M +$206K +11.7% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $2.45M +$693K +39.5% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $2.81M +$1.01M +56.5% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $2.74M +$968K +54.6% Dec 31, 2012 10-K 2014-03-14
Q3 2012 $1.76M +$426K +32% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $1.76M +$284K +19.3% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $1.79M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $1.77M +$1.21M +213% Dec 31, 2011 10-K 2013-03-15
Q3 2011 $1.33M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $1.47M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 $566K Dec 31, 2010 10-K/A 2012-09-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.